reviewNature Reviews Drug DiscoveryAug 10, 2007Closed access

Molecular basis for sunitinib efficacy and future clinical development

Harvard University · Dana-Farber Cancer Institute · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

711
total citations
FWCI
36.83
Percentile
100%
References
67
Citations per year

Authors

4

Topics & keywords

Keywords
  • Sunitinib
  • Sunitinib malate
  • Tyrosine-kinase inhibitor
  • Medicine
  • Imatinib
  • Renal cell carcinoma
  • Tyrosine kinase
  • Stromal cell
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.

Funding